Field intelligence
AI research, companies, regulatory moves, and clinical adoption across neurosurgery.
Browse the Brief →
Independent intelligence for surgical AI
Neurosurgery.ai
Tracking the research, companies, tools, and clinical adoption signals shaping AI in neurosurgery.
A concise briefing every two weeks. No hype, no spam. Read the latest issue →
Latest Brief
Research, tools, and adoption signals in one read.
AI that knows when to defer
Issue 3 · Aug 10, 2026 · 7 min read
Risk prediction, consent agents, clinical workflow, and the case for formal deferral in safety-critical neurosurgical AI.
Neurosurgery Visual Atlas
Complex anatomy, explained as a clinical decision.
Clinician-reviewed, AI-assisted medical illustrations that connect mechanism, imaging, operative anatomy, monitoring, and the point at which a surgeon should pause or defer.
-
01
MechanismWhat is happening?
-
02
EvidenceWhat can imaging and monitoring show?
-
03
Decision boundaryWhat changes management—and what does not?
Neurosurgery.ai Index
A curated tracker for AI-enabled neurosurgical tools.
Index 1.0 begins with eight 2025–2026 FDA records. Every entry links the cleared use to its public evidence and the clinical boundary that the regulatory file does not resolve.
| Record | Workflow | Status | Evidence boundary |
|---|---|---|---|
| Stealth AXiS Cranial | Cranial navigation and planning | FDA K253379 · 2026 | Accuracy V&V; no outcome-superiority claim. |
| Acorn 3D | Spine segmentation and trajectories | FDA K252103 · 2025 | Strong algorithm testing; exclusions require review. |
| JLK-NCCT | ICH and LVO notification | FDA K252421 · 2026 | Triage only; negative output does not exclude disease. |
Two-layer focus
Broad enough to track the field, narrow enough to be useful.
Spinal cord depth
Intramedullary tumors, Chiari, syringomyelia, IONM, and under-covered spinal cord AI.
Explore the focus →Professional boundary
No diagnosis, no patient advice, no image interpretation, and no clinical decision support.
Read the policy →